Related references
Note: Only part of the references are listed.Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jaeger et al.
BLOOD REVIEWS (2020)
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects
Bruno Fattizzo et al.
FRONTIERS IN ONCOLOGY (2020)
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Sigbjorn Berentsen et al.
BLOOD (2020)
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjorn Berentsen
FRONTIERS IN IMMUNOLOGY (2020)
Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program
Georg Gelbenegger et al.
BLOOD ADVANCES (2020)
Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis
Catherine M. Broome et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies
Andres Forero-Torres et al.
BLOOD (2019)
Cold agglutinins: fending off the attack
Sigbjorn Berentsen
BLOOD (2019)
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Ulrich Jaeger et al.
BLOOD (2019)
Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment
Quentin A. Hill et al.
BLOOD ADVANCES (2019)
Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease
Lauren C. Bylsma et al.
BLOOD ADVANCES (2019)
Novel insights into the treatment of complement-mediated hemolytic anemias
Sigbjorn Berentsen et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Cold agglutinin disease: current challenges and future prospects
Sigbjorn Berentsen et al.
JOURNAL OF BLOOD MEDICINE (2019)
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study
Giuseppe Rossi et al.
BLOOD (2018)
How I manage patients with cold agglutinin disease
Sigbjorn Berentsen
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Current and emerging treatment options for autoimmune hemolytic anemia
Wilma Barcellini et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial
Alexander Roeth et al.
BLOOD ADVANCES (2018)
Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation
Catharina Schuetz et al.
BLOOD ADVANCES (2018)
Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease
Agnieszka Malecka et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
The diagnosis and management of primary autoimmune haemolytic anaemia
Quentin A. Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Role of plasma cells in Waldenstrom macroglobulinaemia
Ali El-Ayoubi et al.
PATHOLOGY (2017)
Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
Sigbjorn Berentsen et al.
BLOOD (2017)
Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization
Megan Mullins et al.
BLOOD ADVANCES (2017)
Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity
Agnieszka Malecka et al.
HAEMATOLOGICA (2016)
Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity
Agnieszka Malecka et al.
HAEMATOLOGICA (2016)
ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease
Morie A. Gertz et al.
BLOOD (2016)
Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies
Elisabeth M. Meulenbroek et al.
HAEMATOLOGICA (2015)
Ibrutinib in Previously Treated Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies
Elisabeth M. Meulenbroek et al.
HAEMATOLOGICA (2015)
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria
Antonio M. Risitano et al.
BLOOD (2014)
TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins
Ju Shi et al.
BLOOD (2014)
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
Wilma Barcellini et al.
BLOOD (2014)
Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
Ulla Randen et al.
HAEMATOLOGICA (2014)
Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings
Cathrin Arthold et al.
WIENER KLINISCHE WOCHENSCHRIFT (2014)
C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia
Diana Wouters et al.
BLOOD (2013)
Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia
Sigbjorn Berentsen et al.
BLOOD REVIEWS (2012)
Pathogenic Long-Lived Plasma Cells and Their Survival Niches in Autoimmunity, Malignancy, and Allergy
Oliver Winter et al.
JOURNAL OF IMMUNOLOGY (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
Michel de Weers et al.
JOURNAL OF IMMUNOLOGY (2011)
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
Sigbjorn Berentsen et al.
BLOOD (2010)
Clinical immunology of chronic cold agglutinin disease
Elling Ulvestad et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Paradoxical haemolysis in a patient with cold agglutinin disease
E. Ulvestad
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease
Alexander Roeth et al.
BLOOD (2009)
Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia
Hideki Nakasone et al.
HEMATOLOGY (2009)
Rituximab in chronic cold agglutinin disease:: a prospective study of 20 patients
C Schöllkopf et al.
LEUKEMIA & LYMPHOMA (2006)
Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients
S Berentsen et al.
BLOOD (2004)
Acute phase haemolysis in chronic cold agglutinin disease
E Ulvestad et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Share Paper
